Dr. Chavoustie, Master Implant Physician and Principal Investigator from Segal Institute for Clinical Research, was featured in a recent WIRED magazine article addressing America’s horrific opioid epidemic. “I’ve watched people get their lives back together,” said Dr. Chavoustie. This references Probuphine, an implant that releases buprenorphine into the body. The implant, FDA approved in May of 2016, lasts for six months and protects a patient from withdrawal systems. We are very proud of Dr. Chavoustie’s contribution to the Probuphine clinical trials along with the contributions of all of the Segal Institute’s investigators.
Read the full post below:
